BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16109364)

  • 1. Preclinical Alzheimer's disease: diagnosis and prediction of progression.
    Chong MS; Sahadevan S
    Lancet Neurol; 2005 Sep; 4(9):576-9. PubMed ID: 16109364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
    Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
    Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers in preclinical Alzheimer's disease.
    Chong MS; Lim WS; Sahadevan S
    Curr Opin Investig Drugs; 2006 Jul; 7(7):600-7. PubMed ID: 16869111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mild Cognitive Impairment or pre-demential Alzheimer's disease?].
    Sarazin M; Dubois B
    Rev Neurol (Paris); 2002; 158(10 Suppl):S30-4. PubMed ID: 12529583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early identification of cognitive deficits: preclinical Alzheimer's disease and mild cognitive impairment.
    Small BJ; Gagnon E; Robinson B
    Geriatrics; 2007 Apr; 62(4):19-23. PubMed ID: 17408315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease.
    Hansson O; Buchhave P; Zetterberg H; Blennow K; Minthon L; Warkentin S
    Neurobiol Aging; 2009 Feb; 30(2):165-73. PubMed ID: 17646035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current topics about mild cognitive impairment (MCI)].
    Yamamoto Y
    Seishin Shinkeigaku Zasshi; 2011; 113(6):584-92. PubMed ID: 21815470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semantic knowledge of famous people in mild cognitive impairment and progression to Alzheimer's disease.
    Estévez-González A; García-Sánchez C; Boltes A; Otermín P; Pascual-Sedano B; Gironell A; Kulisevsky J
    Dement Geriatr Cogn Disord; 2004; 17(3):188-95. PubMed ID: 14739543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptoms of apathy are associated with progression from mild cognitive impairment to Alzheimer's disease in non-depressed subjects.
    Richard E; Schmand B; Eikelenboom P; Yang SC; Ligthart SA; Moll van Charante EP; van Gool WA;
    Dement Geriatr Cogn Disord; 2012; 33(2-3):204-9. PubMed ID: 22722671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: the role of depression and apathy.
    Palmer K; Di Iulio F; Varsi AE; Gianni W; Sancesario G; Caltagirone C; Spalletta G
    J Alzheimers Dis; 2010; 20(1):175-83. PubMed ID: 20164594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild cognitive impairment as predictor for Alzheimer's disease in clinical practice: effect of age and diagnostic criteria.
    Visser PJ; Verhey FR
    Psychol Med; 2008 Jan; 38(1):113-22. PubMed ID: 17451628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mild cognitive impairment: A review of the literature].
    Hödl AK; Bonelli RM; Kapfhammer HP
    MMW Fortschr Med; 2005 Jun; 147(23):40-3. PubMed ID: 15981904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fornix and mammillary bodies in older adults with Alzheimer's disease, mild cognitive impairment, and cognitive complaints: a volumetric MRI study.
    Copenhaver BR; Rabin LA; Saykin AJ; Roth RM; Wishart HA; Flashman LA; Santulli RB; McHugh TL; Mamourian AC
    Psychiatry Res; 2006 Oct; 147(2-3):93-103. PubMed ID: 16920336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease.
    Arnáiz E; Almkvist O
    Acta Neurol Scand Suppl; 2003; 179():34-41. PubMed ID: 12603249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies.
    Mitchell AJ; Shiri-Feshki M
    Acta Psychiatr Scand; 2009 Apr; 119(4):252-65. PubMed ID: 19236314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer's disease.
    Geslani DM; Tierney MC; Herrmann N; Szalai JP
    Dement Geriatr Cogn Disord; 2005; 19(5-6):383-9. PubMed ID: 15802914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD.
    Borroni B; Anchisi D; Paghera B; Vicini B; Kerrouche N; Garibotto V; Terzi A; Vignolo LA; Di Luca M; Giubbini R; Padovani A; Perani D
    Neurobiol Aging; 2006 Jan; 27(1):24-31. PubMed ID: 16298237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.